Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2021-10-01
2022-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The HEALiX: Comparing the Efficacy of the HEALiX Device With Wrist Restraints in a Critical Care Setting
NCT05180552
Novel Arm Restraint in the Intensive Care Unit
NCT03621475
Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment
NCT04067622
Pilot Study on Device-assisted Mobilisation of Critically Ill Patients
NCT05716451
What is the Effective Pulmonary Physiotherapy Method in Critically Care Patients?
NCT02645695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Participants will wear HEALiX device
HEALiX
HEALiX is a non-restraint patient safety device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HEALiX
HEALiX is a non-restraint patient safety device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* legally authorized representative must speak English
* admitted by one of the services presiding over the selected intensive care units
* mechanically ventilated receiving analgesic-sedating medications
* have soft wrist restraints applied as part of their care plan documented in the medical record to reduce the risk of unplanned removal of medical devices
Exclusion Criteria
* prisoners
* patients who are in a medically induced coma or in a comatose state (Glasgow Coma Scale \<8) for any reason
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lancaster General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Caplan, DNP-C
Role: PRINCIPAL_INVESTIGATOR
Penn Medicine Lancaster General Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lancaster General Health
Lancaster, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HEALiX IP Pilot
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.